111 Overview
111 (YI) has a ROE of 60.02%, above the Healthcare sector average of 29.03%.
Get informed when a big investor buys or sells
+ Follow60.02%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
111 (YI) currently reports a ROE of 60.02%. That is above the Healthcare sector average of 29.03%. Use the charts on this page to explore 111's ROE history and peer comparisons.
111's ROE of 60.02% is higher than the Healthcare sector average of 29.03%. That is roughly 106.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but 111's current 60.02% should be judged against Healthcare norms (sector average: 29.03%) and against YI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 60.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.03%. From there, open related valuation or income-statement pages for 111, and consider following YI for alerts when major investors trade the stock.
111 is classified in the Healthcare sector. On ROE, it currently shows 60.02% versus a sector average near 29.03%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YI with unrelated industries.
